Skip to main content

Table 2 Second cancers by race

From: Impact of race and tumor subtype on second malignancy risk in women with breast cancer

  Under 50 50 and older
White Black White Black
O/E Excess risk O/E Excess risk O/E Excess risk O/E Excess risk
All sites 1.55# 38.59 2.30# 76.03 1.07# 11.56 1.30# 42.26
All solid tumors 1.59# 37.78 2.37# 72.87 1.10# 14.23 1.34# 42.99
Oral cavity and pharynx 1.25# 0.28 0.98 −0.02 1.05 0.12 0.93 −0.13
Digestive system 1.04 0.35 1.08 0.87 0.97# −1.18 1.10# 3.71
Colon, rectum and anus 0.91# −0.53 0.98 −0.12 0.97# −0.62 1.07 1.51
Pancreas 1.17# 0.23 1.04 0.06 0.92# −0.39 1.07 0.47
Peritoneum, omentum and mesentery 2.11# 0.18 1.96 0.07 0.92 −0.03 1.06 0.01
Respiratory system 1.23# 1.93 1.69# 5.53 0.95# −1.1 1.08 1.73
Bones and joints 1.93# 0.08 2.04 0.07 1.1 0.01 1.22 0.03
Soft tissue including heart 2.16# 0.4 1.81 0.32 1.34# 0.24 1.75# 0.54
Skin excluding basal and squamous 1.20# 0.67 2.03 0.29 1.11# 0.51 1.71# 0.38
Breast 2.18# 30.16 3.91# 60.98 1.30# 12.67 1.89# 31.31
Female genital system 1.32# 3.14 1.47# 3.36 1.17# 2.93 1.22# 3.41
Corpus and uterus, NOS 1.16# 0.84 1.70# 2.24 1.32# 3.02 1.48# 3.69
Ovary 1.97# 2.5 2.00# 1.49 1.07# 0.33 0.97 -0.12
Urinary system 1.13# 0.38 1.14 0.32 1.02 0.19 1.23# 1.68
Brain and other nervous system 1.12 0.1 0.17# −0.34 0.75# -0.4 0.75 −0.23
Endocrine system 1.15# 0.35 2.00# 1.53 1.25# 0.45 1.50# 0.82
Lymphoma 0.93 -0.19 0.96 -0.07 0.89# -0.77 1.04 0.16
Leukemia 1.63# 0.84 3.95# 2.65 1.05 0.23 1.19 0.58
  1. # Indicates P value <0.05